Performance

Today's Low Today's High
42.10
46.51
52 Week Low 52 Week High
24.18 (13-Mar-2024)
47.77 (18-Jul-2024)

Open
44.93
Previous Close
44.30
Volume
-
Total Traded value
-
Upper circuit
39.62
Lower circuit
26.42

Market Depth

Buy Order Quantity Sell Order Quantity
0
0

Bid PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--
Ask PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--

Fundamentals

Market Cap: ₹11.95 Cr
PE Ratio (TTM): -3.63
PB Ratio: 158.21
Industry P/E:-
Debt to Equity:-
ROE:-4342.86
EPS (TTM):-12.19
Book Value:0.00
Face Value: 10.00
Established in November 1994, Parmax Pharma Ltd (PPL) was founded by Jayantilal S Dhol, Purushottam J Bhalodi, and Prabhudas D Hansalpara. The core of Parmax's pharmaceutical operations lies in its Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO) business. Initially, the promoters were engaged in the production of bulk drugs such as Ampicillin, Amoxicillin, Cephalexin, Nalidixic Acid, among others. However, the company ceased its operations for a period due to various reasons. Transitioning from its origins as a bulk drug manufacturer and specialty chemicals producer in 1994, the company subsequently established a facility in Hadamtala, Gujarat, for the manufacturing and marketing of bulk drugs including amoxicillin trihydrate, ampicillin trihydrate, cephalexin monohydrate, and nalidixic acid, with an installed capacity of 96 TPA. The antibiotic project was fully operational as of May 31, 1997.
Company nameListing dateIndustry BSE symbol
Parmax Pharma Ltd Mar, 2017 Pharmaceuticals PARMAX

Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023

  • Promoters 
    30.80%
    Public 
    69.20%
    Shares held by Employee Trusts 
    --%
  • Promoters 
    30.80%
    Public 
    69.20%
    Shares held by Employee Trusts 
    --%
  • Promoters 
    30.80%
    Public 
    69.20%
    Shares held by Employee Trusts 
    --%

Parmax Pharma Ltd FAQ's

What is the range of today's stock performance for Parmax Pharma Ltd?

The stock performance today ranged from a low of 42.10 to a high of 46.51.

What are the 52-week low and high values for Parmax Pharma Ltd?

The 52-week low is 24.18 (on 13-Mar-2024), and the 52-week high is 47.77 (on 18-Jul-2024).

What was the opening and previous closing prices for Parmax Pharma Ltd?

The stock opened at 44.93 and closed at 44.30.

What are the upper and lower circuit limits for Parmax Pharma Ltd?

The upper circuit limit is 39.62, and the lower circuit limit is 26.42.

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Parmax Pharma Ltd?

ROE is -4342.86, EPS is -12.19, book value is not available

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
18
online
2009
Threads
32
Settings

Latest Business News

Back
Top